Farmakologian ja toksikologian laitos
Department of Pharmacology and Toxicology

Julkaisut 2004
Publications 2004

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Aira M, Tacke U. Kuopion yliopistollisen sairaalan huume- ja lääkeriippuvuuspoliklinikan toiminta.
2 Forsberg MM et al. Lack of increased oxidative stress in catechol-O-methyltransferase (COMT)-deficient mice.
3 Gratz S et al. Intestinal mucus alters the ability of probiotic bacteria to bind aflatoxin B1 in vitro.
4 Hakkarainen J et al. TP53 mutation detection by SSCP and sequencing.
5 Hakulinen P et al. Potent inhibition of gap junctional intercellular communication by 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) in BALB/c 3T3 cells.
6 Harju ATK et al. The efficacy of benzyl benzoate sprays in killing the storage mite Tyrophagus putrescentiae (Acari: Acaridae).
7 Huotari M et al. d-Amphetamine responses in catechol-O-methyltransferase (COMT) disrupted mice.
8 Jansson V. Development of Novel Luminescence-Based Enzymatic Assays for Inorganic Pyrophosphate and AMP to Measure Nucleic Acid Polymerization and Ligation.
9 Jarho EM et al. A cyclopent-2-enecarbonyl group mimics proline at the P2 position of prolyl oligopeptidase inhibitors.
10 Kokki H. Current management of pediatric postoperative pain.
11 Kokki H. Lääkkeiden haittavaikutukset lapsilla.
12 Kokki H et al. Ketoprofen for add-on pain treatment to paracetamol after strabismus surgery in children.
13 Kokki H et al. Pharmacokinetics of oxycodone after intravenous, buccal, intramuscular and gastric administration in children.
14 Lahtinen P et al. S(+)-Ketamine as an analgesic adjunct reduces opioid consumption after cardiac surgery.
15 Laitinen K. Voiko tulehduskipulääkkeitä käyttää varfariinihoidon aikana?
16 Laitinen K. Mihin D-vitamiinia tarvitaan?
17 Laitinen K. Mitkä ovat statiinien haitta- ja yhteisvaikutukset?
18 Laitinen K, Raunio H. Varfariini - uutta tietoa vanhasta lääkkeestä.
19 Lampela P et al. Effect of cell-surface glycosaminoglycans on cationic carrier combined with low-MW PEI-mediated gene transfection.
20 Lampela P et al. Synergism in gene delivery by small PEIs and three different nonviral vectors.
21 Linares AF et al. Antioxidant and neuroprotective activity of the extract from the seaweed, Halimeda incrassata (Ellis) Lamouroux, against in vitro and in vivo toxicity induced by methyl-mercury.
22 Lipponen A et al. The role of the chorda tympani nerve and histaminergic system in TCDD toxicity.
23 Loikkanen J. Role of Glutamatergic Neurotransmitter System in the Neurotoxicity of Inorganic Lead.
24 Lozeva V et al. Increased brain serotonin turnover correlates with the degree of shunting and hyperammonemia in rats following variable portal vein stenosis.
25 Lozeva-Thomas V et al. Brain histamine in experimental acute liver failure: effects of l-histidine loading.
26 Lähdesmäki J et al. Alpha2A-adrenoceptors are important modulators of the effects of D-amphetamine on startle reactivity and brain monoamines.
27 Manakova S et al. The roles of dopamine transporter and Bcl-2 protein in the protection of CV1-P cells from 6-OHDA-induced toxicity.
28 Midzianovskaia IS et al. The dopamine and it metabolites concentration in the different structures of WAG/Rij and Wistar rats strains´ brain: the comparative analysis of audiogenic, absence and mixed form epilepsy.
29 Midzyanovskaya IS et al. Brain histaminergic system modulates absence seizures in WAG/Rij RATS.
30 Männistö PT. Catechol-0-methyltransferase and its inhibitors.
31 Pesonen TM et al. Gender-related changes in suicide rates and methods in Eastern Finland from 1988 to 1997.
32 Priha E et al. Exposure to and acute effects of medium-density fiber board dust.
33 Puncuh F et al. Use of spinal anaesthesia in paediatric patients: a single centre experience with 1132 cases.
34 Raunio H. Miten lääkkeiden yhteisvaikutusten riski muodostuu?
35 Raunio H. Lääkkeiden yhteisvaikutukset lapsilla.
36 Raunio H et al. In vitro methods in the prediction of kinetics of drugs: focus on drug metabolism.
37 Saarti J, MacDonald E. Lääkeaineiden verkkotiedonhaun oppiminen osana farmasian verkko-opetusta.
38 Soderstrom H et al. A controlled study of tryptophan and cortisol in violent offenders.
39 Sohlberg A et al. Improving the quality of small animal brain pinhole SPECT imaging by Bayesian reconstruction.
40 Sorokin AYa et al. The interstrain differences in the effects of D-amphetamine and raclopride on dorsal striatum dopaminergic system in KM and Wistar Rats (Microdialysis Study).
41 Stockmann-Juvala H et al. Fumonisin B1 -induced toxicity and oxidative damage in U-118MG glioblastoma cells.
42 Stockmann-Juvala H et al. Oxidative stress induced by fumonisin B1 in continuous human and rodent neural cell cultures.
43 Swamy HVLN et al. Effects of feeding blends of grains naturally contaminated with Fusarium mycotoxins on brain regional neurochemistry of starter pigs and broiler chickens.
44 Turpeinen M et al. Selective inhibition of CYP2B6-catalyzed bupropion hydroxylation in human liver microsomes in vitro.
45 Turrek M et al. Interaktiivisen opetuksen kehittämisestä systemaattisen farmakologian ja lääkeainetoksikologian kurssilla.
46 Venäläinen JI et al. Slow-binding inhibitors of prolyl oligopeptidase with different functional groups at the P1 site.
47 Venäläinen JI et al. Evolutionary relationships of the prolyl oligopeptidase family enzymes.
48 Vähäkangas K. Ethical aspects of molecular epidemiology of cancer.
49 Vähäkangas K. Eettisiä näkökulmia lasten lääkehoitoon ja -tutkimuksiin.
50 Vähäkangas K, Länsimies E. Suostumuskäytäntö ja henkilöllisyyden suoja geenipankkitutkimuksissa.

Farmakologian ja toksikologian laitos Department of Pharmacology and Toxicology
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008